Pravastatin Sodium

CHEMBL690 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
446.5 g/mol
LogP
Phase
4

A sodium salt form of pravastatin with the same therapeutic properties. A statin medication used to lower elevated cholesterol and triglyceride levels in the blood, reducing the risk of heart attacks, strokes, and the need for heart procedures.

Peso molecular

446,5000 g/mol

TPSA

127,00 Ų

Áreas terapéuticas

Mecanismo de acción

Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Competitive inhibitor of HMG-CoA reductase.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+]

InChI

InChI=1S/C23H36O7.Na/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28;/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28);/q;+1/p-1/t13-,14-,16+,17+,18+,19-,20-,22-;/m0./s1

Molecular Formula

C23H35NaO7

HBD / HBA

3 / 7

Enlaces Rotables

11

Átomos Pesados

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A sodium salt form of pravastatin with the same therapeutic properties. A statin medication used to lower elevated cholesterol and triglyceride levels in the blood, reducing the risk of heart attacks, strokes, and the need for heart procedures.

Competitive inhibitor of HMG-CoA reductase.

Yes, Pravastatin Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL690. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 16759173. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.